Programmed drug delivery: nanosystems for tumor targeting.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Drug Delivery Systems

Background:

• Tumor-targeted drug delivery faces challenges in effective extra- and intracellular transport.
• Conventional nanoparticles may lack adaptability for complex biological environments.
• Need for intelligent systems that respond to tumor-specific conditions.

Purpose of the Study:

• To introduce programmed nanoscaled systems for enhanced tumor-targeted drug delivery.
• To explore the mechanisms of nanoparticle adaptation using molecular sensors.
• To highlight the potential of these systems for delivering various therapeutic agents.

Main Methods:

• Incorporation of molecular sensors into nanoparticles to respond to stimuli (pH, enzymes, redox).
• Utilizing tumor-targeting principles: passive and active receptor targeting.
• Employing physical forces (electric/magnetic fields, ultrasound, light, hyperthermia) for focusing and activation.
• Formulating therapeutic nucleic acids (plasmid DNA, siRNA) as 'synthetic viruses' within nanosystems.

Main Results:

• Programmed nanoparticles demonstrate structural and property alterations for optimized delivery.
• Molecular sensors enable responsive behavior to specific tumor microenvironments.
• Integration of physical forces enhances targeting precision and triggered release.
• Successful formulation of nucleic acid-based drugs within adaptable nanosystems.

Conclusions:

• Programmed nanosystems represent a significant advancement in tumor-targeted drug delivery.
• The adaptive nature of these nanoparticles improves therapeutic efficiency.
• These systems hold promise for the next generation of cancer therapeutics, including nucleic acid-based drugs.